Emmanuel Ghandilyan, co-founder and CEO of Foldink, joins us to discuss the world of bioprinting and how bioinks, the source material used to 3D print biological materials, will fuel innovation in regenerative medicine, cell cultured foods, and personalized medicine. Emmanuel shared with us his company’s approach to producing bioinks, and the promise the technology holds for the future of medicine and other advancements in biological sciences.